Healthtech Startups

CCX offers a platform for managing access agreement activities, with a focus on collaboration between payers and pharmaceutical companies. It serves the healthcare and pharmaceutical market.

4 investors

Cedience provides a SaaS platform that uses natural language processing and machine learning to help drug development teams quickly find evidence-backed answers to regulatory questions by centralizing and integrating regulatory databases. The platform serves pharmaceutical and biotech companies navigating drug development and regulatory approval processes.

4 investors

CellChorus develops a visual AI platform called TIMING that performs high-throughput dynamic analysis of single cells, measuring cell activation, killing, and movement over time for biopharmaceutical research. The company serves biopharmaceutical companies and therapy developers seeking to understand cellular function and phenotype.

4 investors

Celularity is a regenerative and cellular medicine company developing and commercializing biomaterial products and allogeneic, cryopreserved cell therapies derived from the postpartum placenta to target age-related diseases. It operates its own integrated manufacturing, translational research, and biobanking facility for placenta-derived cellular medicines and advanced biomaterials.

4 investors

Cenegenics is a physician-led age management and performance health system that uses diagnostics and data-driven interventions to help individuals optimize strength, cognition, metabolic health, and longevity. The company serves individuals seeking personalized, medically grounded approaches to extending peak physical and cognitive performance.

4 investors

Centauri provides data-driven technology and services for U.S. health plans and health systems, turning fragmented clinical data into analytics used for risk adjustment, care coordination, quality optimization, and clinical data exchange. Its solutions target healthcare reimbursement across Medicare, Medicaid, Commercial, and Exchange programs to improve payment accuracy and member outcomes.

4 investors

Centrexion develops therapies for the treatment of pain, focusing on the design and execution of clinical trials for pain drug development. The company operates in the biotechnology and pharmaceutical industry.

4 investors

Ceregate develops brain-computer interface and neuromodulation technologies to improve patient outcomes in neurodisorders. The company brings together expertise in neuroscience, engineering, and medical devices to advance non-invasive neuromodulation solutions.

4 investors

Ceribell is a medical technology company that develops products for detecting and monitoring seizures, including EEG-based diagnostic systems. It serves healthcare providers in the neurodiagnostics and medical device field.

4 investors

CertifyOS operates an API-first, UI-agnostic provider network management platform that automates licensing, enrollment, credentialing, and network monitoring for healthcare organizations and health plans. With direct integrations into hundreds of primary sources, it serves as a centralized source of truth for provider data across the healthcare ecosystem.

4 investors

4 investors

Charco Neurotech develops the CUE1, a non-invasive device that uses vibratory stimulation to ease movement symptoms and improve quality of life for people with Parkinson's disease. The company builds its technology together with and for Parkinson's patients based on ongoing scientific research.

4 investors

Cherry is a point-of-sale financing platform that enables healthcare practices to offer patients buy-now-pay-later payment plans with instant approval and competitive rates.

4 investors

Child Health Imprints develops IoT devices and AI-driven predictive analytics software for neonatal intensive care units, including a bedside surveillance device (NEO), a NICU workflow platform (iNICU), and a post-discharge child growth tracking product (iCHR). Its tools capture real-time vitals data and use machine learning to predict disease onset and severity in neonates for hospitals and clinicians.

4 investors

Cionic develops the Neural Sleeve, an FDA-cleared wearable device that uses electrical muscle stimulation to improve walking and mobility for people with neurological conditions including Multiple Sclerosis, stroke, cerebral palsy, and spinal cord injury. The system combines hardware with an AI-powered app and personalized coaching to help users regain independence and confidence in daily activities.

4 investors

Cipher Surgical develops the OpClear platform, a laparoscopic device that uses CO2 flow and on-demand saline lens washing to keep the endoscope lens clear during complex endoscopic and laparoscopic surgery. It is aimed at surgical teams to maintain continuous intra-abdominal vision, reduce scope removal events, and shorten operating times.

4 investors

Circadia develops an FDA-cleared contactless patient monitoring platform using AI and hardware to enable early detection of patient health changes and reduce rehospitalizations. The platform serves healthcare providers and hospitals seeking to shift from reactive to predictive care delivery.

4 investors

ClarityCare AI builds software for utilization management in health insurance, focusing on prior authorization. Its agents assemble and pre-populate authorization requests and support clinical review against medical necessity criteria, reducing manual processing time. The product is used by third-party administrators and payers handling large volumes of daily cases.

4 investors

ClearDekho sells eyeglasses, sunglasses, and computer glasses through a franchise-based retail model. The company operates physical optical stores and offers franchise opportunities.

4 investors

Clear Gene develops RNA diagnostics for detecting residual solid tumors in cancer patients and provides software and reagent kits to help clinical laboratories process COVID-19 samples more efficiently using existing equipment.

4 investors

Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases. The company translates academic research on cellular senescence into clinical therapeutics.

4 investors

Clearpol provides AI-powered software solutions for post-acute and long-term care providers, including clinical oversight with real-time alerts, automated plan-of-correction generation, and regulatory compliance management. The platform serves skilled nursing facilities and other care operators in the U.S. healthcare sector.

4 investors

Climatic sells an inhalable respiratory product (marketed as "L Max") intended to support easier breathing, reduce mucus buildup, and improve lung function for athletes and everyday users. It is a consumer wellness/health product distributed direct-to-consumer.

4 investors

CRIO develops eSource software for clinical research sites to manage electronic source documentation and trial workflows. The platform serves research sites, sponsors, and CROs in the clinical trials industry.

4 investors